These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1450921

  • 1. Presence of D-alanine in proteins of normal and Alzheimer human brain.
    D'Aniello A, Vetere A, Fisher GH, Cusano G, Chavez M, Petrucelli L.
    Brain Res; 1992 Oct 02; 592(1-2):44-8. PubMed ID: 1450921
    [Abstract] [Full Text] [Related]

  • 2. Free D-aspartate and D-alanine in normal and Alzheimer brain.
    Fisher GH, D'Aniello A, Vetere A, Padula L, Cusano GP, Man EH.
    Brain Res Bull; 1991 Jun 02; 26(6):983-5. PubMed ID: 1933416
    [Abstract] [Full Text] [Related]

  • 3. Quantification of D-aspartate in normal and Alzheimer brains.
    Fisher GH, D'Aniello A, Vetere A, Cusano GP, Chávez M, Petrucelli L.
    Neurosci Lett; 1992 Aug 31; 143(1-2):215-8. PubMed ID: 1436669
    [Abstract] [Full Text] [Related]

  • 4. D-aspartate in human brain.
    Man EH, Fisher GH, Payan IL, Cadilla-Perezrios R, Garcia NM, Chemburkar R, Arends G, Frey WH.
    J Neurochem; 1987 Feb 31; 48(2):510-5. PubMed ID: 3794720
    [Abstract] [Full Text] [Related]

  • 5. Free D-serine concentration in normal and Alzheimer human brain.
    Nagata Y, Borghi M, Fisher GH, D'Aniello A.
    Brain Res Bull; 1995 Feb 31; 38(2):181-3. PubMed ID: 7583345
    [Abstract] [Full Text] [Related]

  • 6. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT, Trojanowski JQ, Lee VM.
    Lab Invest; 1992 Feb 31; 66(2):212-22. PubMed ID: 1735956
    [Abstract] [Full Text] [Related]

  • 7. Reduction of telencephalin immunoreactivity in the brain of patients with Alzheimer's disease.
    Hino H, Mori K, Yoshihara Y, Iseki E, Akiyama H, Nishimura T, Ikeda K, Kosaka K.
    Brain Res; 1997 Apr 11; 753(2):353-7. PubMed ID: 9125424
    [Abstract] [Full Text] [Related]

  • 8. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects.
    Skinner ER, Watt C, Besson JA, Best PV.
    Brain; 1993 Jun 11; 116 ( Pt 3)():717-25. PubMed ID: 8513399
    [Abstract] [Full Text] [Related]

  • 9. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex.
    Hare DJ, Raven EP, Roberts BR, Bogeski M, Portbury SD, McLean CA, Masters CL, Connor JR, Bush AI, Crouch PJ, Doble PA.
    Neuroimage; 2016 Aug 15; 137():124-131. PubMed ID: 27233149
    [Abstract] [Full Text] [Related]

  • 10. Altered aspartate in Alzheimer neurofibrillary tangles.
    Payan IL, Chou SJ, Fisher GH, Man EH, Emory C, Frey WH.
    Neurochem Res; 1992 Feb 15; 17(2):187-91. PubMed ID: 1531702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method.
    Shin RW, Iwaki T, Kitamoto T, Sato Y, Tateishi J.
    Am J Pathol; 1992 Apr 15; 140(4):937-45. PubMed ID: 1373272
    [Abstract] [Full Text] [Related]

  • 13. Racemized D-aspartate in Alzheimer neurofibrillary tangles.
    Fisher GH, Payan IL, Chou SJ, Man EH, Cerwinski S, Martin T, Emory C, Frey WH.
    Brain Res Bull; 1992 Jan 15; 28(1):127-31. PubMed ID: 1540839
    [Abstract] [Full Text] [Related]

  • 14. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type.
    Söderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G.
    J Neurochem; 1992 Nov 15; 59(5):1646-53. PubMed ID: 1402910
    [Abstract] [Full Text] [Related]

  • 15. Neurotrophic factor for central cholinergic neurones is present in both normal and Alzheimer brain tissue.
    Atterwill CK, Bowen DM.
    Acta Neuropathol; 1986 Nov 15; 69(3-4):341-2. PubMed ID: 3962611
    [Abstract] [Full Text] [Related]

  • 16. Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease : a comparative study.
    Zhukareva V, Shah K, Uryu K, Braak H, Del Tredici K, Sundarraj S, Clark C, Trojanowski JQ, Lee VM.
    Am J Pathol; 2002 Oct 15; 161(4):1135-41. PubMed ID: 12368187
    [Abstract] [Full Text] [Related]

  • 17. Elevated levels of a glycoprotein antigen (P-80) in gray and white matter of brain from victims of multiple sclerosis.
    Cruz TF, Quackenbush EJ, Letarte M, Moscarello MA.
    Neurochem Res; 1986 Jun 15; 11(6):877-89. PubMed ID: 2942791
    [Abstract] [Full Text] [Related]

  • 18. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).
    Svennerholm L, Gottfries CG.
    J Neurochem; 1994 Mar 15; 62(3):1039-47. PubMed ID: 8113790
    [Abstract] [Full Text] [Related]

  • 19. A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
    Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB.
    Ann Neurol; 1986 Nov 15; 20(5):616-21. PubMed ID: 2878639
    [Abstract] [Full Text] [Related]

  • 20. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.
    Sasaki H, Muramoto O, Kanazawa I, Arai H, Kosaka K, Iizuka R.
    Ann Neurol; 1986 Mar 15; 19(3):263-9. PubMed ID: 2870679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.